insitro, which uses machine learning for drug discovery and development, raises $143M Series B led by Andreessen Horowitz, bringing total raised to $243M (Leah Rosenbaum/Forbes)

Leah Rosenbaum / Forbes:
insitro, which uses machine learning for drug discovery and development, raises $143M Series B led by Andreessen Horowitz, bringing total raised to $243M  —  When it comes to biotech company Insitro, it’s not the machine learning platform or the cutting-edge biology that lures in investors: it’s the founder and CEO, Daphne Koller.